Johnson & Johnson
JNJleaderJohnson & Johnson is a global healthcare company operating in pharmaceuticals and medical devices. Following the spin-off of its consumer health division as Kenvue, it focuses on innovative medicine and MedTech.
المنتجات والإيرادات
حصة إيرادات المنتج
توزيع الإيرادات ($85.2B)
بيانات ثابتة (تحميل البيانات المالية…)
تكوين القطاعات والعملاء الرئيسيون
تفاصيل المنتج
Pharmaceutical products including immunology, oncology, and neuroscience therapeutics
Surgical instruments, robotics, and interventional solutions
Joint reconstruction, spine, and sports medicine implants
علاقات سلسلة التوريد
السياق الكلي والسوقي
메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요
미국 헬스케어 지출 (2026E)
AI 진단 정확도 개선
UNH 의료손해율
약가 협상 대상 의약품
المحفزات القادمة
إشارات مؤسسية
| المؤسسة | الإجراء | القيمة | الربع | تاريخ التقديم |
|---|---|---|---|---|
| BlackRock | accumulating | $923M | 2024.06 | 2024-08-13↑ |
| BlackRock | reducing | $384M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $358M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $25M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $50M | 2024.06 | 2024-08-13↓ |
| BlackRock | accumulating | $948M | 2024.06 | 2024-08-13↑ |
| BlackRock | reducing | $431M | 2024.06 | 2024-08-13↓ |
| BlackRock | accumulating | $10.9B | 2024.06 | 2024-08-13↑ |
| BlackRock | accumulating | $7.7B | 2024.06 | 2024-08-13↑ |
| BlackRock | accumulating | $714M | 2024.06 | 2024-08-13↑ |
| BlackRock | accumulating | $1.2B | 2024.06 | 2024-08-13↑ |
| BlackRock | reducing | $509M | 2024.06 | 2024-08-13↓ |
| BlackRock | accumulating | $870M | 2024.06 | 2024-08-13↑ |
| BlackRock | reducing | $27M | 2024.06 | 2024-08-13↓ |
| BlackRock | accumulating | $2.5B | 2024.06 | 2024-08-13↑ |
| BlackRock | reducing | $137M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $41M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $515M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $80M | 2024.06 | 2024-08-13↓ |
| BlackRock | reducing | $17M | 2024.06 | 2024-08-13↓ |
| BlackRock | accumulating | $531M | 2024.06 | 2024-08-13↑ |
| Vanguard Group | accumulating | $1.1B | 2025.12 | 2026-01-29↑ |
| Vanguard Group | accumulating | $222M | 2025.12 | 2026-01-29↑ |
| Vanguard Group | accumulating | $44.8B | 2025.12 | 2026-01-29↑ |
| Vanguard Group | accumulating | $2.8B | 2025.12 | 2026-01-29↑ |
| Vanguard Group | accumulating | $828M | 2025.12 | 2026-01-29↑ |
| Vanguard Group | reducing | $11K | 2025.12 | 2026-01-29↓ |
| Vanguard Group | accumulating | $4M | 2025.12 | 2026-01-29↑ |
| State Street | accumulating | $27.7B | 2025.12 | 2026-02-13↑ |
| Wellington Management | accumulating | $4.7B | 2025.12 | 2026-02-17↑ |
| Wellington Management | accumulating | $36M | 2025.12 | 2026-02-17↑ |
| Wellington Management | reducing | $6M | 2025.12 | 2026-02-17↓ |
| Wellington Management | reducing | $2M | 2025.12 | 2026-02-17↓ |
| Wellington Management | reducing | $2M | 2025.12 | 2026-02-17↓ |
| Wellington Management | reducing | $14M | 2025.12 | 2026-02-17↓ |
| Wellington Management | accumulating | $53M | 2025.12 | 2026-02-17↑ |
| Wellington Management | accumulating | $27M | 2025.12 | 2026-02-17↑ |
| FMR (Fidelity) | accumulating | $2.2B | 2025.12 | 2026-02-17↑ |
| FMR (Fidelity) | reducing | $509K | 2025.12 | 2026-02-17↓ |
| FMR (Fidelity) | accumulating | $19M | 2025.12 | 2026-02-17↑ |
| FMR (Fidelity) | accumulating | $1.3B | 2025.12 | 2026-02-17↑ |
| FMR (Fidelity) | accumulating | $43M | 2025.12 | 2026-02-17↑ |
| FMR (Fidelity) | accumulating | $386M | 2025.12 | 2026-02-17↑ |
| FMR (Fidelity) | accumulating | $14M | 2025.12 | 2026-02-17↑ |
آخر الأخبار
تحليل الذكاء الاصطناعي
انقر "احصل على تحليل AI" للحصول على تحليل سلسلة التوريد لـ Johnson & Johnson.
معلومات الشركة
نظرة عامة على القطاع — 헬스케어
أخبار القطاع메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요
미국 헬스케어 지출 (2026E)
AI 진단 정확도 개선
UNH 의료손해율
약가 협상 대상 의약품
الموضوعات الرئيسية
- •CMS 메디케어 어드밴티지 수가 인하 → 보험사 마진 압박
- •AI 영상진단·병리학 도입 가속 — Tempus, Veracyte 수혜
- •GLP-1 보험 적용 확대 논의 → UNH·CVS 비용 증가 리스크
المحفزات القادمة
- ◆CMS 메디케어 최종 수가 발표 (2026.Q2)
- ◆UNH/HUM/CVS Q1 실적 (2026.04)